Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Lifeline Scientific FY11 Profit Rises

4/24/2012 2:49 AM ET

Lifeline Scientific, Inc. (LSI.L) reported that its full-year 2011 net income attributable to co. increased to $3.47 million from $2.20 million last year. On a per share basis, earnings was $0.17 versus 0.12 year-ago.

For the twelve months, net income totaled $3.27 million compared to $1.99 million previous year.

Operating profit for the period decreased to $1.9 million from $4.5 million prior year reflecting planned strategic investments in product development and geographic expansion.

The company's total revenue advanced to $25.39 million from year ago's $23.17 million, primarily due to increased unit sales of LifePort Kidney Transporter and a significant increase in sales of solutions and consumable products.

Click here to receive FREE breaking news email alerts for Lifeline Scientific and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.